Decision Aid
Localized prostate cancer: choosing a treatment
Your cancer is still inside the prostate. That usually means you have time, and you have choices. This page compares the five paths on cancer control, recovery, and side effects.
Last reviewed 2026-06-09
Reading time ~10 min
Print-friendly
A note before you start
This tool does not pick for you. Your urologist and your care team will help you choose.
Use what is below to sort your own priorities before your visit. How much does removing the cancer now matter to you, set against the side effects that come with it? How much do you want to protect how you pee and how sex works? Your team knows your PSA, your Grade Group, your risk group, your age, and your other health. They are the ones who can fit any of this to you. No single path here is the right answer for every man.
For the full picture, read the localized prostate cancer patient guide. It covers Gleason score, Grade Group, your risk group, and each treatment in more depth. This aid is the short version, built to help you compare your options side by side.
Chapter 1 · The decision
What this decision is about
A biopsy has shown prostate cancer. Your scans and exam suggest it is still inside the prostate, with no sign it has spread to lymph nodes or other organs. Doctors call this localized prostate cancer. It is the most common way prostate cancer is found.
Many men feel a strong pull to "just get it out" the moment they hear the word cancer. For some men that instinct fits. For many others, especially those with slow-growing, low-risk cancer, treatment carries side effects that watching closely would have spared them. Most localized prostate cancer grows slowly, so you usually have a few weeks to read, ask questions, and get a second opinion before you decide.
Several paths are reasonable for most men. Which one fits depends on your cancer, your body, and what you care about.
What your care team brings to the choice
Your team weighs many things at once: your PSA, your Grade Group (how the cancer looks under the microscope), and your NCCN risk group, which pulls those together. They also weigh your age, your other health, and how long you are likely to live with and without treatment. Then there is what you most want to protect: how you pee, how sex works, your bowel, or simply avoiding the side effects of treatment for as long as the cancer lets you. They will tell you which paths are reasonable for your cancer. This tool assumes that talk is starting or already going.
Chapter 2 · The five paths
Compare the five main paths
These are the five paths men with localized prostate cancer choose between. Not all five are on the table for every man. Your risk group (Chapter 5) decides which ones are. Read down a column to learn one path. Read across a row to compare them on one thing.
What active surveillance involves
It is easy to hear "we will watch it" and feel you are being asked to ignore a cancer. You are not. Active surveillance is a structured plan with regular PSA tests, MRI scans, and repeat biopsies, plus a clear trigger to treat if the cancer changes. For low-risk cancer, it is the path most guidelines point to first. Watchful waiting (Path 5) is a separate thing, for men unlikely to need treatment at all.
Chapter 3 · Surgery and radiation up close
Within surgery and radiation, you have more choices
Two of the five paths open into a set of their own. If you lean toward surgery, you will pick how it is done. If you lean toward radiation, you will pick which kind. These choices change the daily commitment and the side-effect pattern more than they change cancer control.
Within surgery: how the prostate is removed
The cancer control is similar across surgical approaches. In skilled hands, the differences show up in blood loss, recovery, and the surgeon's own experience, not in whether the cancer comes back. Surgeon experience matters more than which tool is used.
The nerve-sparing question
The nerves that drive erections run right alongside the prostate. During surgery, your surgeon decides whether to spare both, one, or neither. The call depends on where your cancer sits and how far it reaches. Sparing the nerves, when it is safe to do so, is the strongest thing in a surgeon's control for erections recovering afterward.
When the cancer hugs the nerves, sparing them can leave cancer behind, so the surgeon may not be able to. Ask where your cancer sits and whether nerve-sparing is on the table for you. It is one of the most useful questions you can bring to a surgical visit.
Within radiation: which kind
These differ most in the time commitment and the side-effect pattern. Cancer control is broadly similar for localized disease when the right type fits the cancer. Higher-risk cancers often add hormone therapy to radiation. That is a separate decision, covered in the guide.
A note on focal therapy
Focal therapy (such as HIFU or cryotherapy) treats only the part of the prostate with cancer. It is the newest path here and the least settled. Long-term results past 10 years are limited, insurance coverage varies, and cancer can show up later in the untreated part, so you keep getting surveillance. For the right man with a single area of cancer, it is a reasonable option to discuss. It is not a sure cure, and the evidence behind it is weaker than for surgery or radiation.
Chapter 4 · Sex, urine, and bowel
The side effects men weigh most
For most men with localized cancer, the paths are about equally good at controlling the cancer. So the decision often turns on side effects, and above all on how they affect sex, peeing, and the bowel.
Surgery and radiation do not cause their side effects at the same time.
- Surgery causes its effects right away. Leaking and erection trouble start the day the catheter comes out, then improve over the next 1 to 2 years, more for some men than others.
- Radiation causes fewer effects up front. But new bowel, urine, and erection trouble can show up or get worse slowly. This can go on over 1 to 3 years and beyond.
- Active surveillance and watchful waiting change none of this, for as long as you stay on them.
The pictures below show roughly how many men out of 100 have lasting new erection trouble with each active path. These are typical ranges from large studies. Your own odds depend on your age, your erections before treatment, your cancer, and nerve-sparing.
Surgery
Bilateral nerve-sparing, healthier man
Around 30 to 50 of 100 still have erections firm enough for sex at 1 to 2 years, often with the help of pills. Ejaculation ends after surgery for everyone.
Radiation
External beam or brachytherapy
About 30 to 50 of 100 develop new erection trouble. It tends to come on slowly over 3 to 5 years, not right away. Hormone therapy, when added, lowers sex drive and erections while you are on it.
Active surveillance
Watching, no treatment yet
None from the path itself. Your sex life and peeing stay as they are. The cost here is the worry of a watched cancer, not a physical side effect.
The numbers are typical ranges, not promises for your case.
What men do not always hear up front
After surgery, ejaculation ends, orgasm becomes dry, and some men notice the penis is a little shorter. Some men leak a little urine at orgasm in the first year. After radiation, side effects can keep changing for years, and there is a small rise in the risk of a new bladder or rectal cancer over decades, which matters more for a man in his 50s than in his 70s, and a small number of men get lasting bladder irritation or occasional blood in the urine years later, called radiation cystitis. If you are younger and may still want children, ask about banking sperm before treatment.
Chapter 5 · How your risk group narrows the paths
Your risk group decides which paths are on the table
Not all five paths are reasonable for every man. Which ones are depends on your risk group, a rating your team builds from your PSA, your Grade Group, and how the cancer looks on exam and biopsy. This aid does not tell you your group. Your urologist does. But it helps to know how the group changes your options.
The system most US teams use is called NCCN. It sorts localized prostate cancer into bands, from very low risk up to very high risk. The lower your risk, the more watching is on the table. The higher your risk, the more treatment, and sometimes hormone therapy added to radiation, comes into the picture.
Ask for your risk group, in those words
Ask on the first visit: "What is my NCCN risk group, and how does that shape what you are recommending?" The answer tells you which of the five paths are options for you, so you can spend your reading time on the ones that apply to you.
Chapter 6 · Your trade-offs
What you are weighing
The right choice depends on your risk group and on what you most want to protect. Ask yourself:
- If watching is on the table for me, can I live with a cancer that stays in place while we keep an eye on it?
- How much does having the cancer removed, and knowing it is out, matter to me?
- How much do I want to protect erections and how sex works? How much does my partner figure into that?
- How much do I want to protect how I pee, and avoid the leaking that can follow surgery?
- Would I rather have side effects come and then improve, as with surgery? Or stay light up front and build slowly over years, as with radiation?
- Can I commit to weeks of daily radiation visits? Or do I want a single procedure and one recovery?
- How do I weigh my age and my other health against how long this cancer is likely to take to cause trouble?
- If I still want children, do I need to bank sperm before treatment?
Watching first does not close doors
If active surveillance is one of your options and you choose it, surgery, radiation, and the other paths all stay open. Many men watch a low-risk cancer for years and treat it only if it changes. Surgery and radiation, once done, do narrow what comes next, so it helps to know the order before you start.
Chapter 7 · Take these to your appointment
Good questions to ask your team
Print this page, or write these down. The space at the bottom is for your own questions.
- What is my NCCN risk group, and which of the five paths are options for me?
- Is active surveillance reasonable for my cancer? If so, what is the schedule, and what would make us switch to treatment?
- For my cancer, are surgery and radiation about equal on cancer control? Is there a reason to lean one way?
- If I have surgery, can you spare the nerves on one or both sides, and how many of these do you do a year?
- If I have radiation, which type fits my cancer? How many sessions? Would you add hormone therapy?
- Given my age and my health now, what are my own odds of leaking after treatment? What about erection trouble?
- Should my case be reviewed by both urology and radiation oncology, or at a tumor board?
- If I might still want children, how and when do I bank sperm?
My own questions:
Where this information comes from
- National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Prostate Cancer, Version 3.2026.
- European Association of Urology (EAU). Guidelines on Prostate Cancer, 2025.
- Hamdy FC, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer (ProtecT). New England Journal of Medicine, 2023.
- Hamdy FC, et al. Ten-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer (ProtecT). New England Journal of Medicine, 2016.
- Brand DH, et al. Stereotactic body radiotherapy versus conventionally fractionated radiotherapy (PACE-B). Lancet Oncology, 2019.
- Morris WJ, et al. Androgen suppression combined with elective nodal and dose-escalated radiation therapy, with or without a brachytherapy boost (ASCENDE-RT). International Journal of Radiation Oncology, Biology, Physics, 2017.
- Coughlin GD, et al. Robot-assisted versus open radical prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncology, 2018.
- WellPrept clinical brief: Localized Prostate Cancer, 2026-05-05 build, and the WellPrept localized prostate cancer patient guide.
This decision aid does not recommend one path over another. The numbers above reflect typical published ranges; your cancer, your risk group, your age, and your other health may make some paths more or less appropriate, and may take some off the table. Your urologist and your care team are the right people to translate this material to your situation.
WellPrept Decision Aid · localized-prostate-cancer-treatment-choice · v1 · next review 2027-06-09